FierceHealthcare FierceHealthIT FierceMobileHealthcare FierceHealthPayer
FierceHealthFinance FierceEMR FiercePracticeManagemtn Hospital Impact

Syndicate content

Daniel Carpenter news from FierceHealthcare

News

SPOTLIGHT: Revised study still finds that FDA approval rush may cause harm

July 3, 2008 — 12:26am ET | By
Harvard University professor Daniel Carpenter has come out with a revised version of a study concluding that drugs moving too quickly through the FDA approval process are more likely to be linked to Read more...
Related Tags Safety Problems   Fda Approval Process   Harvard University Professor   Food and Drug Administration (FDA)
Tools